http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001009030-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e16720e68a1dae2997fc995b7a2729ff |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate | 1999-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ff5f7fb14c51bd0a6ffb7abb2d93d6 |
| publicationDate | 2001-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001009030-A |
| titleOfInvention | How to inactivate a virus |
| abstract | (57) [Summary] (Modified) [Problem] HIV, HBV, HCV, HTLV-1, H Therapeutic means to prolong the life of a patient infected with a retrovirus, such as TLV-2, porcine endogenous retrovirus (PERV), and to prolong the life of a patient with impaired liver function or renal function. SOLUTION: The blood of a human body is separated outside the body into cells such as red blood cells, white blood cells and platelets, and a plasma component, and the separated plasma component is circulated inside hepatocytes of a different animal to obtain a human plasma component. After decomposing the waste products present in the plant or synthesizing various proteins, enzymes, hormones, amino acids, etc., the plasma components are transmitted to the human liver cells immediately before the plasma components are returned to the human body. And a method of inactivating a dissolved endogenous retrovirus (PERV) by using wave energy generated by ultrasonic vibration, and then combining blood cells with plasma components and allowing the blood to return to the human body. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016201783-A1 |
| priorityDate | 1999-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.